BioDirection said today it raised $2 million in interim financing to support the clinical development of its Tbit point-of-care blood test for concussion diagnosis. The round was joined by Provident Healthcare Capital, MedScience Ventures and others, the Boston-based company said. The financing round brings the total raised for the company up to approximately $12 million. […]
The FDA today announced plans for a workshop to discuss the development of technologies for detecting biomarkers related to traumatic brain injuries. The aim of the workshop is to discuss both the challenges and solutions related to biomarker development methodologies, the FDA said. During the meeting, the agency will seek to establish strategies for standardizing […]
BioDirection said today it raised $4 million in a Series B convertible preferred stock financing round to support its Tbit rapid point-of-care concussion test. The Tbit blood test is designed to detect and measure protein biomarkers released from the brain following head trauma to identify concussions and traumatic brain injuries in less than 90 seconds, […]
Covidien (NYSE:COV) is set to close a $350 million buyout of Israeli lung diagnosis firm superDimension by the end of the week, according to Israeli business journal Calcalist.
Founded in Tel Aviv by Pinchas Gilboa, Minneapolis-based superDimension, which employs about 120 people worldwide, also has offices in Dusseldorf, Germany.